Fig. 4
From: Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Tissue metabolites as biomarkers to differentiate less-aggressive PC (ISUP 2) from more-aggressive PC (ISUP 3). Box plots showing relative abundances for the six metabolite-panel distinguishing less-aggressive PC (ISUP 2) from more-aggressive PC (ISUP 3) in addition with data from benign prostate tissues and PC with ISUP 1 and PC with ISUP 4. Data are expressed as means ± standard deviation and statistical significance was determined using the one-way ANOVA followed by post-hoc Benjamini-Hochberg (FDR, false discovery rate) test and a p-value < 0.05 was considered statistically significant. PC + GPC—peak for combined phosphocholine/glycerophosphocholine metabolites; Glx: combined signal of glutamate/glutamine